FDA approves Amyvid™
6 April 2012
Amyvid is the first and only radioactive diagnostic agent approved for PET imaging of beta-amyloid neuritic plaques in the living brain...
Industry news
FDA decides Teva is sole first-to-file on Provigil®
5 April 2012
Teva Pharmaceuticals USA, is sole first-to-file for both Orange Book patents listed for Provigil® (modafinil)...
Sanofi and Regeneron announce regulatory and clinical update for Zaltrap® (aflibercept)
5 April 2012
The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®...
UCB and Amgen initiate sclerostin antibody Phase 3 program in patients with Postmenopausal Osteoporosis
4 April 2012
The start of sclerostin antibody Phase 3 clinical trial program announced...
GSK receives further data from phase lll studies of albiglutide in type 2 diabetes
3 April 2012
Data from seven studies support progression towards regulatory filings...
Teva announces launch of generic Avapro® and generic Avalide® in the United States
2 April 2012
180-day period of marketing exclusivity awarded...
Novartis QVA149 Phase III COPD studies meet primary endpoints
2 April 2012
QVA149 efficacy, safety and exercise endurance primary endpoints all met[1],[2],[3]...
Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV
2 April 2012
SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir...
Efficacy and safety data for ZOSTAVAX®
2 April 2012
Merck announced that data from the pivotal Phase III study with ZOSTAVAX® in adults ages 50 to 59 were published in the April 1 issue of Clinical Infectious Diseases...
Amgen and AstraZeneca announce collaboration
2 April 2012
Collaboration comprises five monoclonal antibodies brodalumab (AMG 827) Phase 3 trial planned in 2012...
Merial acquires Newport Laboratories
2 April 2012
Merial, the Animal Health division of Sanofi, announced that it has acquired Newport Laboratories...
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content